Literature DB >> 16943284

Papillomavirus particles assembled in 293TT cells are infectious in vivo.

Timothy D Culp1, Nancy M Cladel, Karla K Balogh, Lynn R Budgeon, Andres F Mejia, Neil D Christensen.   

Abstract

Papillomaviruses (PVs) demonstrate both tissue and species tropisms. Because PVs replicate only in terminally differentiating epithelium, the recent production of infectious PV particles in 293 cells marks an important breakthrough. In this article, we demonstrate that infectious PV particles produced in 293TT cells can cause papillomatous growths in the natural host animal. Moreover, we show that species-matched PV genomes can be successfully delivered in vivo by a heterologous, species-mismatched PV capsid. Additionally, our results indicate that the addition of the simian virus 40 origin of replication to the papillomavirus genome increases the production of infectious papillomavirus particles by increasing genome amplification in the transfected 293TT cells.

Entities:  

Mesh:

Year:  2006        PMID: 16943284      PMCID: PMC1642142          DOI: 10.1128/JVI.01328-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  6 in total

1.  Maturation of papillomavirus capsids.

Authors:  Christopher B Buck; Cynthia D Thompson; Yuk-Ying S Pang; Douglas R Lowy; John T Schiller
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

2.  A rapid in vitro polyomavirus DNA replication assay.

Authors:  Katja Ziegler; Thomas Bui; Richard J Frisque; Andrew Grandinetti; Vivek R Nerurkar
Journal:  J Virol Methods       Date:  2004-12-01       Impact factor: 2.014

3.  Production of infectious human papillomavirus independently of viral replication and epithelial cell differentiation.

Authors:  Dohun Pyeon; Paul F Lambert; Paul Ahlquist
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-15       Impact factor: 11.205

4.  Quantitative RT-PCR assay for HPV infection in cultured cells.

Authors:  Timothy D Culp; Neil D Christensen
Journal:  J Virol Methods       Date:  2003-08       Impact factor: 2.014

5.  Kinetics of in vitro adsorption and entry of papillomavirus virions.

Authors:  Timothy D Culp; Neil D Christensen
Journal:  Virology       Date:  2004-02-05       Impact factor: 3.616

6.  Efficient intracellular assembly of papillomaviral vectors.

Authors:  Christopher B Buck; Diana V Pastrana; Douglas R Lowy; John T Schiller
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

  6 in total
  22 in total

1.  A cryo-electron microscopy study identifies the complete H16.V5 epitope and reveals global conformational changes initiated by binding of the neutralizing antibody fragment.

Authors:  Hyunwook Lee; Sarah A Brendle; Stephanie M Bywaters; Jian Guan; Robert E Ashley; Joshua D Yoder; Alexander M Makhov; James F Conway; Neil D Christensen; Susan Hafenstein
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

2.  Preparation and properties of a papillomavirus infectious intermediate and its utility for neutralization studies.

Authors:  Joshua W Wang; Subhashini Jagu; Kihyuck Kwak; Chenguang Wang; Shiwen Peng; Reinhard Kirnbauer; Richard B S Roden
Journal:  Virology       Date:  2013-12-20       Impact factor: 3.616

3.  Papillomavirus infection requires gamma secretase.

Authors:  Balasubramanyam Karanam; Shiwen Peng; Tong Li; Christopher Buck; Patricia M Day; Richard B S Roden
Journal:  J Virol       Date:  2010-08-11       Impact factor: 5.103

4.  Durable immunity to oncogenic human papillomaviruses elicited by adjuvanted recombinant Adeno-associated virus-like particle immunogen displaying L2 17-36 epitopes.

Authors:  Subhashini Jagu; Balusubramanyam Karanam; Joshua W Wang; Hatem Zayed; Margit Weghofer; Sarah A Brendle; Karla K Balogh; Kerstin Pino Tossi; Richard B S Roden; Neil D Christensen
Journal:  Vaccine       Date:  2015-09-15       Impact factor: 3.641

5.  Bovine papillomavirus type 1 infection is mediated by SNARE syntaxin 18.

Authors:  Valerie Laniosz; Kha C Nguyen; Patricio I Meneses
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

6.  Two highly conserved cysteine residues in HPV16 L2 form an intramolecular disulfide bond and are critical for infectivity in human keratinocytes.

Authors:  Samuel K Campos; Michelle A Ozbun
Journal:  PLoS One       Date:  2009-02-13       Impact factor: 3.240

7.  Human papillomavirus type 16 infection of human keratinocytes requires clathrin and caveolin-1 and is brefeldin a sensitive.

Authors:  Valerie Laniosz; Sarah A Dabydeen; Mallory A Havens; Patricio I Meneses
Journal:  J Virol       Date:  2009-06-03       Impact factor: 5.103

Review 8.  Human papilloma virions in the laboratory.

Authors:  Eileen F Dunne; Lauri E Markowitz; La'shan D Taylor; Elizabeth R Unger; Cosette M Wheeler
Journal:  J Clin Virol       Date:  2014-06-23       Impact factor: 3.168

9.  Tissue-spanning redox gradient-dependent assembly of native human papillomavirus type 16 virions.

Authors:  Michael J Conway; Samina Alam; Eric J Ryndock; Linda Cruz; Neil D Christensen; Richard B S Roden; Craig Meyers
Journal:  J Virol       Date:  2009-08-05       Impact factor: 5.103

10.  Human papillomavirus type 31 uses a caveolin 1- and dynamin 2-mediated entry pathway for infection of human keratinocytes.

Authors:  Jessica L Smith; Samuel K Campos; Michelle A Ozbun
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.